R&D The future of Oxford: Science, technology, and collaboration In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
R&D Biopharma’s future in Ireland: Stability, regulation & talen... As increasing global competition from incentives is felt globally, Ireland needs to become even more agile.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
